Aveir VR Real-World Evidence Post-Approval Study
NCT: NCT05270499 · ACTIVE_NOT_RECRUITING
NCT IDNCT05270499
StatusACTIVE_NOT_RECRUITING
Start Date2022-06-21
Completion2034-09-30
Brief Summary
The purpose of this post-approval study is to evaluate the long-term safety of the single-chamber Aveir VR leadless pacemaker using real-world evidence methods.
Frequently Asked Questions
What is Aveir VR Real-World Evidence Post-Approval Study?
Aveir VR Real-World Evidence Post-Approval Study is a clinical trial registered under NCT05270499. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05270499?
The current status of NCT05270499 (Aveir VR Real-World Evidence Post-Approval Study) is: ACTIVE_NOT_RECRUITING.
When did Aveir VR Real-World Evidence Post-Approval Study start?
Aveir VR Real-World Evidence Post-Approval Study started on 2022-06-21.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.